Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Influenza and Other Respiratory Viruses|November 11, 2017
2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among childrenEsther Kissling, Marta Valenciano, Francisco Pozo, et al.
International Journal of Molecular Sciences|May 27, 2023
Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV NetworkSonia Vázquez-Morón, María Iglesias-Caballero, José Antonio Lepe, et al.
Vaccine: X|October 30, 2019
Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18)Esther Kissling, Francisco Pozo, Silke Buda, et al.
Spine|January 15, 2004
Correlation between pain, disability, and quality of life in patients with common low back painFrancisco M Kovacs, Víctor Abraira, Javier Zamora, et al.
Revista Espanola De Salud Publica|October 21, 2014
[cycEVA study: case control study measuring influenza vaccine effectiveness in Spain, 2008-2013]Silvia Jiménez-Jorge, Salvador de Mateo Ontañón, Camelia Savulescu, et al.
Pediatrics|April 5, 2026
Influenza Vaccine Effectiveness in European Primary Care Pediatric Practices: 2022-2024Héloïse Lucaccioni, Marine Maurel, Gloria Pérez-Gimeno, et al.
Influenza and Other Respiratory Viruses|July 26, 2022
COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in SpainClara Mazagatos, Concepción Delgado-Sanz, Susana Monge, et al.
Influenza and Other Respiratory Viruses|January 26, 2023
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre studyEsther Kissling, Francisco Pozo, Iván Martínez-Baz, et al.
Expert Review of Vaccines|March 12, 2026
Vaccine effectiveness against medically-attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25Héloïse Lucaccioni, Francisco Pozo, Gloria Pérez-Gimeno, et al.
Influenza and Other Respiratory Viruses|February 25, 2024
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital networkAngela M C Rose, Francisco Pozo, Iván Martínez-Baz, et al.
Pageof 21